激活可溶性瓜尼利基环酶可以减轻缺血性损伤
Falk-Bach Lichtenberger1, Minze Xu1, Cem Erdoğan1
1Institute of Translational Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Kidney international
|November 21, 2024
概括
用BAY 60-2770直接激活可溶性瓜尼利基环酶 (sGC),通过改善血液流动和减少损伤,保护脏免受急性损伤和过渡到慢性脏疾病.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性损伤 (AKI) 可以发展为慢性病 (CKD),其特点是微血管损伤,炎症和纤维化.
- 目前针对AKI的治疗方法缺乏针对CKD过渡的特殊保护机制.
- 溶性甘基环酶 (sGC) 激活剂提供了一个潜在的治疗策略,独立于氧化.
研究的目的:
- 为了研究新型sGC激活剂BAY 60-2770.的保护作用,BAY 60-2770.
- 在AKI模型中评估sGC激活对脏微血管,血流,纤维化和炎症的影响.
- 为了确定sGC激活是否可以减轻从AKI到CKD的进展.
主要方法:
- 用于诱导AKI的一边性缺血再注射损伤 (IRI) 的老鼠模型.
- 动物接受了载体或sGC激活器BAY 60-2770后IRI.
- 功能,组织学,基因表达和微血管参数在不同的时间点 (第3,7,14和84天) 进行了评估.
- 还进行了使用暴露于缺氧或TGF-β的人类管状细胞 (HK-2) 的体外研究.
主要成果:
- 用车辆治疗的老鼠表现出微血管狭窄,炎症,纤维化和损伤标志物的增加.
- BAY 60-2770治疗增加了组织cGMP,扩大了脏微血管,改善了脏血液流动和氧化.
- sGC激活剂治疗显著降低了的体重减轻,细胞损伤,纤维化,炎症,并改善了血肌素和囊素C水平.
- 在体外,BAY 60-2770调节了压力下的管状细胞中的基因表达模式.
结论:
- 用BAY 60-2770直接激活sGC在AKI模型中显示出显著的保护作用.
- 这种干预通过保护微血管和减少病理变化来减轻AKI到CKD的进展.
- sGC激活是预防病进展的有前途的治疗方法.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:09GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
01:28Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
479
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
479